🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free → 🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free → 🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free →

KLOW Peptide Blend — KLOW-80

For In-Vitro Laboratory Research Use Only • Not for Human or Veterinary Use

KLOW peptide on this page means KLOW-80: an 80mg research blend in a single sealed vial, supplied as freeze-dried powder. Each vial contains GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg and KPV 10mg (£85.99).

The published batch certificate is Lingda Laboratory report LDA22161252 (listed on our verification page). On Lingda reports the Client is the manufacturer/supplier, not Corex Vitality™; we publish the file exactly as issued. Match the batch / report number to the vial label.

For laboratory research use only. Not for human consumption.

£85.99 / vialFrom £73.09 / vial (15% Multi-Vial Savings)

6 in stock

6 in stock

🧪 MULTI-VIAL RESEARCH SAVINGS Buy 2 Save 10% · Buy 3+ Save 15%
1 Vial Standard £85.99 / vial
Buy 2 Vials Save 10% £77.39 / vial
Buy 3+ Vials Save 15% £73.09 / vial
Mix & match vials — 10% off 2 vials and 15% off 3+ vials auto-applies in your basket + Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99.
💧 Reconstitution Bundle: add 10ml Bacteriostatic Water (£5.99) with any lyophilised peptide — FREE on orders over £100.
💧 + Add 10ml BAC Water (£5.99 / Free £100+)
Ways to pay. You place the order first, then pay by a secure payment link (all major credit and debit cards including Visa, Mastercard and American Express, Apple Pay, Google Pay, PayPal including Pay in 3, or a Zilch virtual card) or by UK bank transfer.

FOR IN-VITRO LABORATORY RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE

These products are research chemicals. They are not medicines, food, or supplements. They have not been evaluated by the MHRA, FDA, or any other regulatory body. Not intended to diagnose, treat, cure, or prevent any disease. All descriptions are for reference and research documentation purposes only. By purchasing, you confirm you are aged 18+ and using these products exclusively for in vitro laboratory research.

What is KLOW peptide?

KLOW peptide is the name used here for the KLOW-80 research blend. It combines four components in fixed amounts in one 80mg vial, supplied as freeze-dried powder: GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg and KPV 10mg.

For laboratory research use only. Not for human consumption.

What does the KLOW blend contain?

Component Amount per vial Share of total
GHK-Cu 50mg 62.5%
BPC-157 10mg 12.5%
TB-500 10mg 12.5%
KPV 10mg 12.5%
Total 80mg 100%

GHK-Cu is a copper complex of the tripeptide Gly-His-Lys. BPC-157 is a synthetic peptide with 15 amino acids. TB-500 is a synthetic research peptide. KPV is the tripeptide Lys-Pro-Val.

The product is supplied as freeze-dried powder in a sealed vial. Research on one component does not establish the properties of the combined blend.

Batch COA

The published KLOW-80 certificate is Lingda Laboratory report LDA22161252, listed on our verification page. The verification listing shows HPLC purity >99.72% ± 0.18% (test date 2026-09-03). On Lingda reports the Client is the manufacturer/supplier, not Corex Vitality™; we publish the file exactly as issued.

Match the batch / report number on the certificate with the vial label. Read the results and methods shown in that report. A COA describes the tested sample; it does not establish suitability for any purpose outside laboratory research. Do not treat the Client field as Corex Vitality™ unless the report (or the lab portal) names Corex Vitality™ or The Peptide Corex Limited.

Our testing guide, How to verify a peptide COA (UK) and Reading an HPLC chromatogram explain how to read a certificate.

Storage

Keep the dry vial tightly closed, protected from light and moisture. For longer storage, keep it at −20°C or colder. For short-term storage, keep it in a laboratory fridge at 2–8°C.

Before opening, allow the sealed vial to reach room temperature to reduce moisture on the powder. Follow the batch documentation and your laboratory’s safety procedures. Practical notes on reconstituting lyophilised material are in our peptide reconstitution and storage guide.

KLOW-80 pen format

The same four-component blend is also listed as a pre-filled KLOW-80 pen (80mg, £109.99) on the peptide pens page, filled fresh to order, sealed and boxed. A KLOW-80 Refill Pen is the pen only plus 6 new needles, with no hard case or box (£94.99). All formats are for in-vitro laboratory research only.

Further information

See the KLOW-80 video or visit the Learning Hub for further background. A literature summary of GHK-Cu and KLOW-80 composition is also on the GHK-Cu and Klow-80 research page.

For laboratory research use only. Not for human consumption.

KLOW peptide FAQs

What is KLOW peptide?

KLOW peptide refers here to KLOW-80, a four-component laboratory research blend supplied as 80mg of freeze-dried powder in a sealed vial. For laboratory research use only. Not for human consumption.

What is in the KLOW-80 blend?

Each vial contains GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg and KPV 10mg. The total is 80mg. These are the amounts of material per vial, not instructions.

Where can I find the KLOW-80 batch COA?

Open Lingda Laboratory report LDA22161252 on our verification page and match its batch / report number to the vial label. On Lingda reports the Client is the manufacturer/supplier, not Corex Vitality™; we publish the file exactly as issued. Read the report for the results and methods for that sample.

How should KLOW-80 be stored?

Keep the sealed dry vial away from light and moisture. The current storage guidance is −20°C or colder for longer storage, or 2–8°C for short-term storage. Follow the batch documentation and laboratory procedures.

Does research on one component establish the properties of KLOW-80?

No. Findings about an individual component cannot automatically be applied to the combined blend. Keep component research separate from the product’s composition and batch test results.

Is KLOW-80 also listed as a pen?

Yes. The same 80mg four-component blend is listed as a pre-filled pen at £109.99 on the peptide pens page. A refill pen (pen plus 6 new needles, no hard case or box) is listed at £94.99.

For laboratory research use only. Not for human consumption.

Related reading

Additional information

Size

80mg

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Cover of the free guide: How to read a COA

Free guide

How to read a COA

Get it by email, plus our research updates. No spam, unsubscribe any time.

We will email you to confirm first, then send the guide. We use your name and email only to send you these emails. Privacy policy. For laboratory research use only.

Listed on PepmarketVerified on PeptideReview
🎬 Scientific Explainer Video · What It Is For & How It Works

Klow-80 — Laboratory Mechanism & Research Overview

⬇ Download Video (MP4) All Peptide Videos →
🔬 What Is This Peptide Researched For?
  • Investigating 4-pathway extracellular matrix, angiogenic, cytoskeletal and anti-inflammatory synergy
  • Studying alpha-MSH C-terminal tripeptide KPV (Lys-Pro-Val) inhibition of NF-kB & pro-inflammatory cytokines
  • Evaluating combined copper-tripeptide collagen remodelling with BPC-157 and TB-500 migration kinetics
⚙️ How Does It Work? (Mechanism of Action)
1. Four Orthogonal Target Engagement: GHK-Cu delivers bioavailable Cu2+; BPC-157 activates VEGFR2/FAK; TB-500 binds G-actin; KPV enters via PepT1.
2. NF-kB Suppression + FAK/Akt Activation: KPV blunts nuclear NF-kB translocation while BPC-157/TB-500 drive endothelial & fibroblast motility.
3. Coordinated ECM & Barrier Remodelling: Up-regulates collagen/decorin synthesis while calming inflammatory signalling cascades.
📚 Peer-Reviewed Literature · PubMed Indexed

Published Research — Peer-Reviewed Receptor & Pathway Studies

NCBI PubMed Database ↗ Verify Batch COAs →

KLOW-80 Quad-Blend (GHK-Cu + BPC-157 + TB-500 + KPV)

  1. [1] Chavatte P et al. · J Pharm Pharmacol (2001)

    Two-dimensional 1H-NMR spectroscopy and molecular-mechanics conformational analysis of the α-MSH(11–13) C-terminal tripeptide Ac-Lys-Pro-Val-NH2 (KPV), defining its folded trans-proline secondary structure in solution.

    PMID: 11480545 ↗ DOI: 10.1211/0022357011776360 ↗
  2. [2] Dalmasso G et al. · Gastroenterology (2008)

    In-vitro Caco-2, HT29-Cl.19A, and Jurkat T-cell study demonstrating that the oligopeptide transporter PepT1 mediates intracellular uptake of the KPV tripeptide to inhibit NF-κB and MAPK pro-inflammatory signalling cascades.

    PMID: 18061177 ↗ DOI: 10.1053/j.gastro.2007.10.026 ↗
  3. [3] Land SC · Int J Physiol Pathophysiol Pharmacol (2012)

    In-vitro bronchial epithelial cell study demonstrating that the tripeptide KPV suppresses TNF-α- and respiratory syncytial virus-induced NF-κB nuclear translocation and IL-8/eotaxin chemokine secretion.

    PMID: 22837805 ↗
  4. [4] Songok AC et al. · PLoS One (2018)

    Synthetic peptide chemistry and NMR spectroscopic characterisation of modified Lys-Pro-Val (KPV) tripeptide derivatives engineered to resist proteolytic aminopeptidase degradation in biological matrices.

    PMID: 29953505 ↗ DOI: 10.1371/journal.pone.0199686 ↗

GHK-Cu (Copper Tripeptide-1)

  1. [1] Pickart L et al. · Nature (1980)

    Foundational biochemical and structure-function study demonstrating that the histidyl-lysyl tripeptide chelates copper(II) in equimolar coordination and facilitates cellular copper transport in cultured hepatoma cells.

    PMID: 7453802 ↗ DOI: 10.1038/288715a0 ↗
  2. [2] Maquart FX et al. · FEBS Lett (1988)

    In-vitro fibroblast culture study showing picomolar-to-nanomolar (10^-12 to 10^-9 M) stimulation of collagen biosynthesis by the GHK–Cu(II) coordination complex independent of cell-number changes.

    PMID: 3169264 ↗ DOI: 10.1016/0014-5793(88)80509-x ↗
  3. [3] Wegrowski Y et al. · Life Sci (1992)

    Radiolabelled [3H]-glucosamine and [35S]-sulfate incorporation assay in cultured human fibroblasts demonstrating biphasic stimulation of extracellular dermatan sulfate and cell-layer heparan sulfate synthesis at 10^-9 to 10^-8 M GHK-Cu.

    PMID: 1522753 ↗ DOI: 10.1016/0024-3205(92)90504-i ↗
  4. [4] Mehr A et al. · Acta Crystallogr D Struct Biol (2020)

    X-ray crystallographic structural study resolving the high-affinity square-pyramidal copper(II) coordination sphere formed by the N-terminal GHK tripeptide motif in recombinant fusion proteins.

    PMID: 33263328 ↗ DOI: 10.1107/S2059798320013741 ↗

BPC-157 (Pentadecapeptide)

  1. [1] Chang CH et al. · J Appl Physiol (1985) (2011)

    Ex-vivo rat Achilles tendon explant and cultured tendon fibroblast study demonstrating concentration-dependent acceleration of cellular migration, culture-dish spreading, H2O2 stress survival, and FAK–paxillin phosphorylation.

    PMID: 21030672 ↗ DOI: 10.1152/japplphysiol.00945.2010 ↗
  2. [2] Hsieh MJ et al. · J Mol Med (Berl) (2017)

    In-vitro human vascular endothelial cell and chick chorioallantoic membrane (CAM) study showing upregulated VEGFR2 mRNA/protein expression, receptor internalisation, and VEGFR2–Akt–eNOS phosphorylation.

    PMID: 27847966 ↗ DOI: 10.1007/s00109-016-1488-y ↗
  3. [3] Chang CH et al. · Molecules (2014)

    cDNA microarray, RT-qPCR, and Western blot study in isolated rat Achilles tendon fibroblasts showing concentration- and time-dependent upregulation of growth hormone receptor expression and downstream JAK2 phosphorylation.

    PMID: 25415472 ↗ DOI: 10.3390/molecules191119066 ↗
  4. [4] Huang T et al. · Drug Des Devel Ther (2015)

    In-vitro human umbilical vein endothelial cell (HUVEC) transwell, scratch-migration, and Matrigel tube-formation assays demonstrating concentration-dependent cell-cycle progression and ERK1/2, FAK, and paxillin phosphorylation.

    PMID: 25995620 ↗ DOI: 10.2147/DDDT.S82030 ↗

TB-500

  1. [1] Safer D, Elzinga M, Nachmias VT · J Biol Chem (1991)

    Biochemical study showing that the actin-sequestering peptide Fx and thymosin beta 4 are the same molecule, and describing how it binds actin monomers.

    PMID: 1999398 ↗
  2. [2] Hannappel E · Ann N Y Acad Sci (2007)

    Review of the beta-thymosin peptide family: structure, distribution and known molecular interactions, including actin binding.

    PMID: 17468232 ↗ DOI: 10.1196/annals.1415.018 ↗
  3. [3] Philp D et al. · FASEB J (2003)

    In-vitro endothelial cell adhesion, migration, tube-formation, and chick aortic-ring sprouting study demonstrating that the conserved central 7-amino-acid G-actin-binding motif reproduces the angiogenic signalling of full-length thymosin β4.

    PMID: 14500546 ↗ DOI: 10.1096/fj.03-0121fje ↗
  4. [4] Bock-Marquette I et al. · Nature (2004)

    Embryonic and postnatal cardiomyocyte culture and biochemical study showing that the G-actin-sequestering polypeptide thymosin β4 forms a functional PINCH–integrin-linked kinase (ILK) complex that activates protein kinase B (Akt) signalling.

    PMID: 15565145 ↗ DOI: 10.1038/nature03000 ↗

References are provided for scientific context only. All Corex Vitality™ compounds are supplied strictly for in-vitro laboratory research use (RUO).